Vitamin D metabolism in human prostate cells: Implications for prostate cancer chemoprevention by vitamin D

Anticancer Research

Volumn 26, Issue 4 A, 2006, Pages 2567-2572

  Flanagan, John N ^a   Young, Michael V ^a   Persons, Kelly S ^a   Wang, Lilin ^a   Mathieu, Jeffrey S ^a   Whitlatch, Lyman W ^a   Holick, Michael F ^a   Chen, Tai C ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemoprevention; Cytochrome P450; Hydroxylases; Prostate cancer; Vitamin D

Indexed keywords

CALCITRIOL; COLECALCIFEROL; CYTOCHROME P450 3A4; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3; THYMIDINE;

ARTICLE; CANCER CHEMOTHERAPY; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; VITAMIN D METABOLISM; WESTERN BLOTTING;

CALCIFEDIOL; CALCITRIOL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHOLECALCIFEROL; CYTOCHROME P-450 CYP27A1; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; PROSTATIC NEOPLASMS; RNA, MESSENGER; STEROID HYDROXYLASES; UP-REGULATION;

EID: 33746644285     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Omdahl JL, Morris HA and May BK: Hydroxylase enzyme of the vitamin D pathway: expression, function, and regulation. Annu Rev Nutr 22: 139-166, 2002.
2. Jones G, Strugnell SA and DeLuca HF: Current understanding of the molecular actions of vitamin D. Physiol Rev 78: 1193-231, 1998.
3. Hewison M and Adams JS: Extra-renal 1α-hydroxylase activity and human disease. In: Vitamin D, Second edition (Feldman D, Pike J and Glorieux F, eds.). Academic Press, pp. 1379-1400, 2005.
4. Gascon-Barre M: The vitamin D 25-hydroxylase. In: Vitamin D, Second edition. Feldman D, Pike J and Glorieux F (eds.). Academic Press, pp. 47-67, 2005
5. Ohyama Y and Yamasaki T: Eight cytochrome P450s catalyze vitamin D metabolism. Front Biosci 9: 3007-3018, 2004.
6. 3. Cancer Epidemiol Biomark Prev 7: 391-395, 1998.
7. 2 for prostate cancer therapy. Clin Cancer Res 6: 901-908, 2000.
8. Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69: 842-856, 1999.
9. 3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes. J Invest Dermatol 104: 113-117, 1995.
10. Chen TC, Turner AK and Holick MF: Methods for the determination of the circulating concentration of 25-hydroxyvitamin D. J Nutr Biochem 1: 315-319, 1990.
11. Chen TC, Turner AK and Holick MF: A method for the determination of the circulating concentration of 1,25-dihydroxyvitamin D. J Nutr Biochem 1: 320-327, 1990.
12. 3 are mediated exclusively through the genomic signaling pathway. Endocrinology 137: 1554-1561, 1996.
13. 3 growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. J Urol 165: 1319-1324, 2001.
14. 3. Endocrinology 136: 20-26, 1995.
15. 3-hydroxylases. Steroids 66: 399-408, 2001.
16. Flanagan JN, Rust DW, Tangpricha V, Chen TC and Holick HF: Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of the vitamin D pathway in UV irradiated keratinocytes. In: Biologic Effects of Light. Holick MF (ed.). Boston, Kluwer, pp. 403-408, 2001.
17. Lehmann B and Meurer M: Extrarenal sites of calcitriol synthesis: the particular role of the skin. Rec Results Cancer Res 164: 135-145, 2003.
18. 3. Am J Physiol 245: 359-364, 1983.
19. Gupta RP, Hollis BW, Patel SB, Patrick KS and Bell NH: CYP3A4 is a human microsomal vitamin D 25-hydroxylase. J Bone Miner Res 4: 680-688, 2004.
20. Cheng JB, Motola DL, Mangelsdorf DJ and Russell DW: De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J Biol Chem 278: 38084-38093, 2003.
21. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ and Russell DW: Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci 101: 7711-7715, 2004.
22. Chen TC and Holick MF: Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol Metab 14: 423-430, 2003.
23. Zhao XY and Feldman D: The role of vitamin D in prostate cancer. Steroids 66: 293-300, 2001.